Page last updated: 2024-08-23

miglustat and B16 Melanoma

miglustat has been researched along with B16 Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guerrera, M; Ladisch, S1
Branza-Nichita, N; Costin, GE; Dwek, RA; Negroiu, G; Petrescu, AJ; Petrescu, SM; Titu, H1

Other Studies

2 other study(ies) available for miglustat and B16 Melanoma

ArticleYear
N-butyldeoxynojirimycin inhibits murine melanoma cell ganglioside metabolism and delays tumor onset.
    Cancer letters, 2003, Nov-10, Volume: 201, Issue:1

    Topics: 1-Deoxynojirimycin; Animals; Cell Division; Cell Line, Tumor; Ceramides; Disease Progression; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gangliosides; Glucosyltransferases; Melanoma, Experimental; Mice; Neoplasm Transplantation

2003
Investigation of the intracellular transport of tyrosinase and tyrosinase related protein (TRP)-1. The effect of endoplasmic reticulum (ER)-glucosidases inhibition.
    Cellular and molecular biology (Noisy-le-Grand, France), 1999, Volume: 45, Issue:7

    Topics: 1-Deoxynojirimycin; Animals; Biological Transport, Active; Endoplasmic Reticulum; Glucosidases; Glycosylation; Intracellular Fluid; Melanoma, Experimental; Melanosomes; Membrane Glycoproteins; Mice; Microscopy, Electron; Monophenol Monooxygenase; Neoplasm Proteins; Oxidation-Reduction; Oxidoreductases; Protein Conformation; Protein Processing, Post-Translational; Proteins; Tumor Cells, Cultured

1999